Overview

Growth Hormone for the Treatment of Gastroparesis

Status:
RECRUITING
Trial end date:
2027-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with Growth Hormone results in symptomatic improvement in patients with gastroparesis.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Growth Hormone
somapacitan